Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Filgotinib for Crohn's Disease
Recruiting1 awardPhase 3
Dothan, Alabama
This trial is testing a new drug for Crohn's disease in both people who have never taken a biologic drug and people who have. The goal is to see if it is safe and effective. People who finish the study or don't respond well can enter a long-term extension study.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service